
4DMedical Ltd
ASX:4DX

Intrinsic Value
The intrinsic value of one
4DX
stock under the Base Case scenario is
0.39
AUD.
Compared to the current market price of 0.305 AUD,
4DMedical Ltd
is
Undervalued by 22%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
4DMedical Ltd
Fundamental Analysis
Want a deep‑dive on 4DMedical Ltd?
Request it below and we’ll move it up the queue.

Revenue & Expenses Breakdown
4DMedical Ltd
Balance Sheet Decomposition
4DMedical Ltd
Current Assets | 22.7m |
Cash & Short-Term Investments | 16m |
Receivables | 3.5m |
Other Current Assets | 3.2m |
Non-Current Assets | 79.3m |
PP&E | 7.9m |
Intangibles | 71.3m |
Other Non-Current Assets | 44.8k |
Free Cash Flow Analysis
4DMedical Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
4DMedical Ltd
Revenue
|
5.9m
AUD
|
Cost of Revenue
|
-374.6k
AUD
|
Gross Profit
|
5.5m
AUD
|
Operating Expenses
|
-45m
AUD
|
Operating Income
|
-39.5m
AUD
|
Other Expenses
|
-72.2k
AUD
|
Net Income
|
-39.5m
AUD
|
4DX Profitability Score
Profitability Due Diligence
4DMedical Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Score
4DMedical Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
4DX Solvency Score
Solvency Due Diligence
4DMedical Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Score
4DMedical Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
4DX Price Targets Summary
4DMedical Ltd
According to Wall Street analysts, the average 1-year price target for
4DX
is 0.799 AUD
with a low forecast of 0.657 AUD and a high forecast of 1.05 AUD.
Dividends
Current shareholder yield for 4DX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
4DX
stock under the Base Case scenario is
0.39
AUD.
Compared to the current market price of 0.305 AUD,
4DMedical Ltd
is
Undervalued by 22%.